KyungDong Pharm Co., Ltd. launches Alzheimer's dementia treatment drug “Donepem Tablet” on May 1, 2020.

 


“Donepem tablets,” which contain donepezil as the main ingredient, play a role in improving cognitive function by increasing the concentration of acetylcholine in dementia patients.

 


It is released in two strengths, 5mg and 10mg, and the dose can be increased depending on symptoms, and can be administered and fed from the early to advanced stages of Alzheimer's type dementia.

In addition, when used in combination with memantine preparations, nursing care benefits are recognized if symptoms of moderate or severe dementia in the form of Alzheimer's disease (including Alzheimer's disease accompanied by cerebrovascular disease) meet the reimbursement standards for each drug.


We hope that the launch of KyungDong Pharm Co., Ltd.'s new product “Donepem Tablet” will help treat dementia patients, which are rapidly increasing due to aging.


 

 

 

 

▣ Product Information ▣

 


Product Name

Donepem tablet 5mg

Donepem tablet 10mg

Ingredient content

5mg as donepezil hydrochloride

10mg as donepezil hydrochloride

Indications

Treatment of Alzheimer's type dementia symptoms

Dosage and usage

Adults: 5 mg once daily before bedtime.

Administer at a dose of 5 mg for 4 to 6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg.

-Elderly women who are underweight should not exceed 5mg per day.

Reimbursement Prices

2,060 won

2,460 won

Reimbursement Code

648104420

648104430

Packaging unit

30 tablets/bottle

30 tablets/bottle

 

※ Please refer to the product manual for other details such as precautions for use.